| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.01 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.11 | 0.02 |